Tag: tumor
Wider access to clinical trials necessary to democratize precision oncology: Report
While advancements in targeted therapies and biomarker discovery show promise, challenges like tumor complexity and unequal access remain
AI’s ability to detect tumor cells could improve bone cancer prognoses
Researchers have developed a new machine-learning model that can precisely make prognosis predictions for patients with osteosarcoma, based on the density of viable tumor cells post-treatment
Biologics to garner $120 billion worth sales revenue by 2027, predicts...
Biologics are poised to emerge as dominating molecule type in solid tumor indication, overtaking innovative small molecules in terms of sales revenue, according to GlobalData
Study finds a new potential therapeutic target for cancer
A new study by a team of scientists at the National Centre for Cell Science (DBT-NCCS) in Pune has provided fresh insights on proteins, β-TrCP1 and β-TrCP2, whose deregulation has been associated with many diseases, including cancer........................
#WorldBrainTumorDay: Timely access to advanced care critical to cure brain tumor
Due to the pandemic, the patients with brain tumors too are suffering due to lack of timely intervention, writes Dr Anandh Balasubramaniam..............................
MedGenome launches tumor mutation burden test for better understanding of immuno-therapy
The test will help clinicians identify how many mutations occur in a given length of DNA to understand whether immunotherapy would work in cancer patients.................
Nucleic acid isolation & purification market players prioritize DNA isolation kits...
As per the latest study, in comparison with RNA isolation kits, manufacturers continue to increase innovations and production of DNA isolation kits, as the category is expected to account for a larger share in the market during the forecast period..................
Regulatory support, big pharma interest will boost precision medicine for cancer
The leading market analysis firm, GlobalData has predicted that the precision medicine approaches for for tumor agnostic development will accelerate due to the enhanced regulatory support and interest from big pharmaceutical players in the market...………..
‘Cold’ glioblastoma tumors require combination therapies to improve response rates, says...
It is the most common form of grade IV brain cancer and considered to be one of the most ‘immune-cold’ tumors relative to other cancers, which limits the effectiveness of immunotherapies................
Personalized cancer treatment 2.0: new combination strategy developed
For the first time, an approach to target different cell groups within single tumors based on their respective characteristics has been developed by the scientists from Netherlands Cancer Institute in Amsterdam, in collaboration with the biotechnology company Genmab A/S.............